C16 Biosciences: Funding, Investors & Team (Oct 2026)
C16 Biosciences was established in 2017 with the objective of utilizing microbiology to create sustainable alternatives to palm oil. The firm's goal is to offer producers, refiners, traders, and consumers of palm oil an opportunity to invest part of their production into bio-based oils and sustainability initiatives, which would help reduce the environmental impact of palm oil production and safeguard natural land, wildlife, and resources. C16 Biosciences believes that fermenting palm oil, similar to brewing beer, is the most effective method of creating a truly sustainable alternative. As a result of their efforts, consumers can enjoy their favorite products without having to worry about the devastating impact of unethically produced palm oil on wildlife and communities.
C16 Biosciences has raised $26.0M across 4 funding rounds on record, the most recent an undisclosed round of $1.0M announced in Jan 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
C16 Biosciences Company Profile and Key Stats
Latest funding round on record: Jan 2024.
C16 Biosciences Funding Rounds
1 of 4 rounds was announced without a disclosed amount and is excluded from the total.
C16 Biosciences raised $20.0M in an undisclosed round announced in Mar 2020.
3 years later, an undisclosed round of $5.0M was announced in Mar 2023.
7 months later, an undisclosed round was announced in Oct 2023 with no disclosed amount.
3 months later, an undisclosed round of $1.0M was announced in Jan 2024.
C16 Biosciences Founders and Leadership Team
Contact details for the C16 Biosciences team: 2 of 2 have an email address on file.
Start 14-day free trial →C16 Biosciences Funding Compared to Other Biotechnology Startups
C16 Biosciences' latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like C16 Biosciences in Biotechnology and New York
Companies Similar to C16 Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
C16 Biosciences Funding FAQs
What does C16 Biosciences do?
C16 Biosciences was established in 2017 with the objective of utilizing microbiology to create sustainable alternatives to palm oil. The firm's goal is to offer producers, refiners, traders, and consumers of palm oil an opportunity to invest part of their production into bio-based oils and sustainability initiatives, which would help reduce the environmental impact of palm oil production and safeguard natural land, wildlife, and resources. C16 Biosciences believes that fermenting palm oil, similar to brewing beer, is the most effective method of creating a truly sustainable alternative. As a result of their efforts, consumers can enjoy their favorite products without having to worry about the devastating impact of unethically produced palm oil on wildlife and communities.
How much funding has C16 Biosciences raised?
C16 Biosciences has raised $26.0M across 4 rounds on record. The most recent is an undisclosed round of $1.0M announced in Jan 2024.
When did C16 Biosciences last raise funding?
C16 Biosciences' most recent funding round on record is an undisclosed round of $1.0M, announced in Jan 2024.
Who founded C16 Biosciences?
FundedIQ lists David Heller (Founder) at C16 Biosciences.
Who is the CEO of C16 Biosciences?
Shara Ticku is listed as CEO at C16 Biosciences.
Where is C16 Biosciences headquartered?
C16 Biosciences is based in New York, United States.
How many employees does C16 Biosciences have?
C16 Biosciences is in the 11-50 employee band.
How does C16 Biosciences' funding compare to other Biotechnology startups?
C16 Biosciences' latest round of $1.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's C16 Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for C16 Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.